FDA APPROVES BIOTRONIK CLS PACEMAKERS

Biotronik announced that it has received FDA approval to market its Protos CLS family of pacemakers as responding to physiologic demands instigated by exercise and acute mental stress. Proprietary technology embedded in these pacemakers, called closed loop stimulation (CLS), integrates with the natural control centers of the heart to provide a physiologic and appropriate heart rate.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050624005462&newsLang=en)